Le Hong Luyen, Jullian Valérie, Claparols Catherine, Vansteelandt Marieke, Haddad Mohamed, Cabou Cendrine, Deharo Eric, Fabre Nicolas
Université de Toulouse, UPS, UMR 152 Pharma-DEV, Université Toulouse 3, Faculté des Sciences Pharmaceutiques, F-31062, Toulouse cedex 09, France; Institut de Recherche pour le Développement (IRD), UMR 152 Pharma-DEV, F-31062, Toulouse cedex 09, France.
Phytochem Anal. 2015 Mar-Apr;26(2):111-8. doi: 10.1002/pca.2542. Epub 2014 Nov 27.
Simalikalactone E (SkE) from Quassia amara, has been proved to be a valuable anti-malarial and anti-cancer compound. As SkE is very scarce, methods of quantitation are needed in order to optimise its isolation process and to determine pharmacokinetic data.
To validate methods using liquid chromatography coupled to mass spectrometry for the quantitation of SkE in plant extracts and in biological fluids.
High- and ultrahigh-performance liquid chromatography (UHPLC) coupled to ion trap mass spectrometry (MS) with single ion monitoring detection and to triple quadrupole-linear ion trap tandem mass spectrometry with multiple reaction monitoring detection methods were developed. Validation procedure was realised according to the International Conference on Harmonisation guideline. Methanol extracts of dried Quassia amara leaves, and mouse-blood samples obtained after various routes of administration, were analysed for SkE.
Methods were validated and gave similar results regarding the content of SkE expressed per kilogram of dry leaves in the traditional decoction (160 ± 12 mg/kg) and in the methanol extract (93 ± 2 mg/kg). The recovery of the analyte from mouse blood ranged from 80.7 to 119.8%. Simalikalactone E was only detected using UHPLC-MS/MS (0.2 ± 0.03 mg/L) in mouse blood after intravenous injection: none was detected following intraperitoneal or oral gavage administration of SkE.
The LC-MS methods were used for the quantitation of SkE in plant extracts and in mouse blood. These methods open the way for further protocol optimisation of SkE extraction and the determination of its pharmacokinetic data.
从苦木中提取的西玛卡内酯E(SkE)已被证明是一种有价值的抗疟疾和抗癌化合物。由于SkE非常稀少,需要定量方法来优化其分离过程并确定药代动力学数据。
验证使用液相色谱-质谱联用技术对植物提取物和生物体液中SkE进行定量的方法。
开发了高效液相色谱(HPLC)和超高效液相色谱(UHPLC)联用离子阱质谱(MS)的单离子监测检测方法,以及联用三重四极杆-线性离子阱串联质谱的多反应监测检测方法。根据国际协调会议指南进行验证程序。对干燥的苦木叶甲醇提取物以及经不同给药途径后获得的小鼠血液样本进行SkE分析。
方法得到验证,传统煎剂(160±12mg/kg)和甲醇提取物(93±2mg/kg)中每千克干叶所含SkE的含量结果相似。分析物从小鼠血液中的回收率在80.7%至119.8%之间。静脉注射后仅在小鼠血液中使用UHPLC-MS/MS检测到西玛卡内酯E(0.2±0.03mg/L):腹膜内或口服灌胃给予SkE后未检测到。
LC-MS方法用于植物提取物和小鼠血液中SkE的定量。这些方法为进一步优化SkE提取方案及其药代动力学数据的测定开辟了道路。